Clinical Trials

Formal Study Name

Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-cel) Out-of-Specification (OOS) in Patients With Multiple Myeloma

Histology

Multiple Myeloma

Trial Type

Interventional

Principal Investigator

Salil Goorha, MD

Locations Where Open

• Baptist Cancer Center-Memphis Malignant Hematology & Stem Cell Clinic
• Baptist Cancer Center-Walnut Grove

Formal Study Name

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Histology

Follicular Lymphoma

Trial Phase

3

Trial Type

Interventional

Principal Investigator

Salil Goorha, MD

Locations Where Open

• Baptist Cancer Center-Humphreys
• Baptist Cancer Center-Walnut Grove
• Baptist Cancer Center-Bartlett
• Baptist Cancer Center-Collierville
• Baptist Cancer Center - DeSoto

Formal Study Name

Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy

Histology

Adenocarcinoma

Stage

4

Treatment Phase

Metastatic

Trial Phase

2

Trial Type

Interventional

Principal Investigator

Donald Gravenor, MD

Locations Where Open

• Baptist Cancer Center-Humphreys
• Baptist Cancer Center-Memphis Thoracic Multidisciplinary Care
• Baptist Cancer Center-Bartlett
• Baptist Cancer Center-Collierville
• Baptist Cancer Center - DeSoto

Formal Study Name

Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors

Histology

Neuroendocrine

Treatment Phase

Adjuvant

Trial Phase

2

Trial Type

Interventional

Principal Investigator

Stephen Behrman, MD

Locations Where Open

• Baptist Cancer Center-Humphreys
• Baptist Cancer Center-Walnut Grove
• Baptist Cancer Center-Bartlett
• Baptist Cancer Center-Collierville
• Baptist Cancer Center - DeSoto

Formal Study Name

Observational study to describe effectiveness of olaparib in subjects with metastatic castration-resistant prostate cancer who have failed prior treatment with a new hormonal agent and carry selected homologous recombination repair gene mutations

Treatment Phase

Advanced

Trial Type

Observational

Principal Investigator

Osa Ogbeide, MD

Locations Where Open

• Baptist Cancer Center-Humphreys
• Baptist Cancer Center-Walnut Grove
• Baptist Cancer Center-Bartlett
• Baptist Cancer Center-Collierville
• Baptist Cancer Center - DeSoto
• Baptist Cancer Center-Grenada
• Baptist Cancer Center- Golden Triangle Columbus
• Baptist Cancer Center- Golden Triangle Starkville

Formal Study Name

A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Treatment Phase

Adjuvant

Trial Phase

2

Trial Type

Interventional

Principal Investigator

Stephen Behrman, MD

Locations Where Open

• Baptist Cancer Center-Humphreys
• Baptist Cancer Center-Walnut Grove
• Baptist Cancer Center-Bartlett
• Baptist Cancer Center-Collierville
• Baptist Cancer Center - DeSoto
• Baptist Cancer Center-Grenada
• Baptist Cancer Center- Golden Triangle Columbus
• Baptist Cancer Center- Golden Triangle Starkville

Formal Study Name

A Randomized Phase III Blinded Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula

Trial Phase

3

Trial Type

Interventional

Principal Investigator

Stephen Behrman, MD

Locations Where Open

• Baptist Cancer Center-Humphreys
• Baptist Cancer Center-Walnut Grove

Formal Study Name

Mobile Health for Adherence in Breast Cancer Patients

Histology

HR+, HER2-

Trial Type

Interventional

Principal Investigator

Hannah Alley, PharmD

Locations Where Open

• Baptist Cancer Center-Humphreys
• Baptist Cancer Center-Walnut Grove
• Baptist Cancer Center-Bartlett
• Baptist Cancer Center-Collierville
• Baptist Cancer Center - DeSoto
• Baptist Cancer Center-Grenada
• Baptist Cancer Center- Golden Triangle Columbus
• Baptist Cancer Center- Golden Triangle Starkville
• Baptist Cancer Center Infusion Center- Jackson, MS

Formal Study Name

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Histology

Adenocarcinoma

Stage

2 to 3

Treatment Phase

Adjuvant

Trial Phase

3

Trial Type

Interventional

Principal Investigator

Sohail Minhas, MD

Locations Where Open

• Baptist Cancer Center-Humphreys
• Baptist Cancer Center-Walnut Grove
• Baptist Cancer Center-Bartlett
• Baptist Cancer Center-Collierville
• Baptist Cancer Center - DeSoto
• Baptist Cancer Center- Golden Triangle Columbus
• Baptist Cancer Center- Golden Triangle Starkville
• Baptist Cancer Center-Grenada

Formal Study Name

International Registry for Men with Advanced Prostate Cancer

Treatment Phase

Advanced

Trial Type

Observational

Principal Investigator

Osa Ogbeide, MD

Locations Where Open

• Baptist Cancer Center-Humphreys
• Baptist Cancer Center-Walnut Grove
• Baptist Cancer Center-Bartlett
• Baptist Cancer Center-Collierville
• Baptist Cancer Center - DeSoto
• Baptist Cancer Center-Grenada
• Baptist Cancer Center- Golden Triangle Columbus
• Baptist Cancer Center- Golden Triangle Starkville